Cytogen

EUSA Pharma to Acquire US Specialty Oncology Company Cytogen

Acquisition of US Infrastructure Completes Build of EUSA's Transatlantic Commercialization Platform US$22.6 Million Acquisition Expands EUSA's Product Portfolio EUSA Raises Over US$50 Million to Fund Acquisition and Other Investments DOYLESTOWN, Pennsylvania and OX...

DOR BioPharma Appoints Christopher P. Schnittker, CPA, as Vice President of Administration and Controller

... publicly held life science companies. Prior to joining DOR, he served in the senior financial roles for VioQuest Pharmaceuticals Inc., Micromet Inc., cytogen Corporation and Genaera Corporation, all publicly traded, R&D-focused companies in the biotechnology and specialty pharmaceuticals arenas. Mr. Sch...

US Brachytherapy Market to Reach $1.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

... the lucrative market. Major players profiled in the report include Best Medical International Inc, BrachySciences Inc, C. R. Bard Inc, Core Oncology, cytogen Corporation, Cytyc Corporation, Eckert & Ziegler Strahlen- und Medizintechnik AG, International Brachytherapy SA, Oncura, Inc., Theragenics Corpo...

Strategic Diagnostics Appoints Kevin J. Bratton as Chief Financial Officer

...Business Operations for EUSA Pharma (USA), Inc. in Langhorne, Pennsylvania. Mr. Bratton had been Senior Vice President and Chief Financial Officer of cytogen Corporation in Princeton, New Jersey prior to its acquisition by EUSA Pharma, Inc. in May 2008. Mr. Bratton has over 35 years of experience in ...

HistoRx Names Kate Adams Vice President, Diagnostics Marketing and Retains Steve Chubb as Strategic Advisor

...d-leading point-of-care diagnostics company. Prior to that, he held the positions of CEO and Chairman of T Cell Sciences, Inc. and CEO and Chairman of cytogen Corp. Mr. Chubb holds an M.B.A. from the Kellogg School of Management at Northwestern University and is a graduate of the U.S. Naval Academy . ...

Cytogen in Medical Technology

CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation

...t of its commitment to advancing the treatment and care of cancer patients, cytogen launched CARE OM(TM) (http://www.careom.com ) a Web-based education and su...d completed several significant transactions, including the acquisitions of cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi ...

One-Third of Patients Discontinue Common Breast Cancer Therapy

... be an attractive option for women who do not like pills or cannot swallow pills. SOLTAMOX is approved by the FDA and is available in the U.S. through cytogen Corporation. For more information about SOLTAMOX, please visit www.soltamoxus.com. -0- WHO: Linda Vahdat, MD, Weill Cornell Medical Center. Dr. V...

New Clinical Data for Cytogen's Quadramet and Prostacint to be Reported at Upcoming Major Medical Meetings

..., the study also assessed response rates. Today, cytogen also reported that new data from an outcomes study...osure policies mandated by the meeting organizers, cytogen will summarize the contents of these studies at th...al suspicion of occult metastatic disease. About cytogen Founded in 1980,...

Preclinical Data on Cytogen's Technology to be Reported at the AACR Annual Meeting

...ning efforts and external research collaborations, cytogen is exploring strategic transactions for AxCell Bio...de in animal models has been demonstrated. About cytogen cytogen is a specialty pharmaceutical company dedicated to...

Cytogen Reports Publication Validating the Utility of its Proprietary ProChart Database

...ning efforts and external research collaborations, cytogen is exploring strategic transactions for AxCell Bio...reagents (eg, cloned domains and ligands). About cytogen cytogen is a specialty pharmaceutical company dedicated to...

New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting

... CHICAGO--(BUSINESS WIRE)--Jun 4, 2007 - cytogen Corporation (NASDAQ: CYTO) today reported results ... scale.) Society of Nuclear Medicine Abstracts cytogen also reported today the presentation of a number o...ken for 12 hours following administration. About cytogen ...

Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop

...mib and should be studied further in this setting. cytogen is committed to developing and commercializing inn...nt advance in clinical therapy of myeloma. About cytogen cytogen is a specialty pharmaceutical company dedicated to...

More>>

Cytogen in Biological Technology

EUSA Pharma Completes Acquisition Of Cytogen Corporation

DOYLESTOWN, Pennsylvania and OXFORD, England, May 9 /PRNewswire/ -- EUSA Pharma Inc ('EUSA'), a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has completed its acquisition of Cytogen Corporation, following the approv...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

... Biomira Announces Results of Stimuvax Phase 2 Clinical Study II-64 cytogen Receives FDA Clearance for CYT-500 IND Application II-64 US Researchers...ech and Celgene Terminate Agreement for Satraplatin II-70 EUSA Acquires cytogen Corporation II-70 Eisai Acquires MGI Pharma II-70 BN ImmunoTherapeu...

Allegro Diagnostics Expands Board and Executive Team

...complishes these clinical objectives." Earlier in his career Mr. Chubb founded and served as Chairman, President & CEO of T Cell Sciences and cytogen Corporation. Previously, Mr. Chubb worked for Baxter Corporation, where he served as President of the Hyland Diagnostics Division.   &n...

Pharmos Corporation Announces Board and Management Changes

...he early formations of private companies such as Sonomed, Immunicon, PharmaStem (formerly Biocyte), ExSAR and Targent. Mr. Johnston served as CEO of cytogen from July 1988 to April 1989. He is also a member of the Advisory Council of the Department of Molecular Biology at Princeton University and the Execu...